Details for Patent: 12,636,285
Which drugs does patent 12,636,285 protect, and when does it expire?
Patent 12,636,285 protects CABENUVA KIT and is included in one NDA.
This patent has fourteen patent family members in eleven countries.
Summary for Patent: 12,636,285
| Title: | Method for treating HIV with cabotegravir and rilpivirine |
| Abstract: | Invented are methods for treating HIV in a human in need thereof which comprises the administration of a therapeutically effective amount of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, to such human. |
| Inventor(s): | Herta Maria Ludovica CRAUWELS, Susan L. FORD, David Andrew MARGOLIS, Stefaan Louis F. ROSSENU, William Robert SPREEN, Rodica Mihaela VAN SOLINGEN-RISTEA, Peter Evan Owen WILLIAMS |
| Assignee: | Janssen Pharmaceutica NV , Janssen Sciences Ireland ULC , ViiV Healthcare Co |
| Application Number: | US19/227,593 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,636,285
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212888-001 | Jan 21, 2021 | RX | Yes | No | 12,636,285 | ⤷ Start Trial | TREATMENT OF HIV-1 INFECTION IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 35 KG | ⤷ Start Trial | ||||
| Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212888-002 | Jan 21, 2021 | RX | Yes | Yes | 12,636,285 | ⤷ Start Trial | TREATMENT OF HIV-1 INFECTION IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 35 KG | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,636,285
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020358156 | ⤷ Start Trial | |||
| Brazil | 112022006267 | ⤷ Start Trial | |||
| Canada | 3155587 | ⤷ Start Trial | |||
| Chile | 2022000790 | ⤷ Start Trial | |||
| China | 114502166 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
